Elevidys Gene Therapy has Arrived in Brazil and Could Cost up to 20 Million Brazilian Reais

The Elevidys gene therapy was approved by the Brazilian Health Regulatory Agency (Anvisa). However, the cost of the treatment, which is 2.9 million US dollars, is causing concern among Brazilian families.

There is no definitive treatment for Duchenne muscular dystrophy (DMD). The Elevidys gene therapy is a treatment method that slows down the disease, and it is not known how long its effect will last.

Elevidys, approved by the Brazilian Health Regulatory Agency (Anvisa), has brought joy to families battling the disease, but the high cost of the treatment is making them feel pessimistic. [Read More: Duchenne Muscular Dystrophy: Treatment & Cost]

The price of gene therapy in Brazil will vary by state. Each Brazilian state has a different tax system. In Maranhão, the product is thought to reach 20 million Brazilian reais. In regions such as São Paulo, Rio de Janeiro, and Minas Gerais, the cost of the treatment could be between 18 million and 19 million Brazilian reais.

Learn More: Frequently Asked Questions About Elevidys

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here


Hot Topics

Related Articles